In November 2017, a study into the effectiveness of percutaneous coronary intervention (PCI) caught international attention for raising questions about the benefits of angioplasty and stenting. The study, Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA), concluded there was no benefit for patients with stable angina who underwent PCI.
Heart failure is an epidemic in the United States, with over 6 million patients suffering from some type of heart failure. While the majority of these patients will be treated medically or with traditional surgery, in some cases, these treatments will ultimately fail.
When it comes to complex coronary cases, the multidisciplinary team at Baylor Scott & White The Heart Hospital – Plano has created a collaborative, coordinated approach to determining the right option for those needing coronary revascularization.
In patients with atrial fibrillation (AFib) who are at risk for bleeding, left atrial appendage closure is often considered instead of oral anticoagulation as a possibility to reduce the risk of stroke. As left atrial appendage closure options have expanded to include new occlusion devices in recent years, Baylor Scott & White The Heart Hospital – Plano has responded through a team approach.
In patients with risk factors or symptoms of thoracic aortic disease, early identification and management often provide for expanded treatment options and a reduction in acute events. The Aortic Center, a part of Baylor Scott & White The Heart Hospital – Plano’s Center for Advanced Cardiovascular Care, offers a comprehensive, proactive approach to diagnosing, monitoring and treating these conditions.
